FRED STUART KANTOR
Pilots at Wellington Dr, Orange, CT
License number
Connecticut A0984039
Issued Date
Apr 2016
Expiration Date
Apr 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
52 Wellington Dr, Orange, CT 06477
Professional information
B. Burgdorferi Polypeptides
US Patent:
6716591, Apr 6, 2004
Filed:
Sep 14, 1998
Appl. No.:
09/152588
Inventors:
Richard A. Flavell - Killingworth CT
Erol Fikrig - Guilford CT
Tuan T. Lam - San Jose CA
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Tuan T. Lam - San Jose CA
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Assignee:
Yale University - New Haven CT
International Classification:
G01N 3353
US Classification:
435 722, 435 71, 435 72, 530350, 5303871, 5303891
Abstract:
Methods and compositions for the prevention, treatment and diagnosis of Lyme disease. Novel polypeptides, serotypic variants thereof, fragments thereof and derivatives thereof. Fusion proteins and multimeric proteins comprising same. Multicomponent vaccines comprising novel polypeptides in addition to other immunogenic polypeptides. DNA sequences, recombinant DNA molecules and transformed host cells useful in the compositions and methods. Antibodies directed against the novel polypeptides, and diagnostic kits comprising the polypeptides or antibodies.
Compositions And Methods Comprising Dna Sequences Encoding B. Burgdorferi Polypeptides
US Patent:
6344552, Feb 5, 2002
Filed:
May 31, 1995
Appl. No.:
08/455973
Inventors:
Richard A. Flavell - Killingworth CT
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Assignee:
Yale University - New Haven CT
International Classification:
A61K 3902
US Classification:
536 237, 536 234, 4352523, 4353201, 435 691, 435 693, 435 711, 435 712, 4242031, 4242001, 4241901, 4241921, 4241841, 4241851
Abstract:
Methods and compositions for the prevention and diagnosis of Lyme disease. OspA and OspB polypeptides and serotypic variants thereof, which elicit in a treated animal the formation of an immune response which is effective to treat or protect against Lyme disease as caused by infection with. Anti-OspA and anti-OspB antibodies that are effective to treat or protect against Lyme disease as caused by infection with. A screening method for the selection of those OspA and OspB polypeptides and anti-OspA and anti-OspB antibodies that are useful for the prevention and detection of Lyme disease. Diagnostic kits including OspA and OspB polypeptides or antibodies directed against such polypeptides.
Compositions And Methods For The Prevention And Diagnosis Of Lyme Disease
US Patent:
6197301, Mar 6, 2001
Filed:
May 31, 1995
Appl. No.:
8/455829
Inventors:
Richard A. Flavell - Killingworth CT
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Assignee:
Yale University - New Haven CT
International Classification:
A61K 3816, A61K 3902
US Classification:
4241901
Abstract:
Methods and compositions for the prevention and diagnosis of Lyme disease. OspA and OspB polypeptides and serotypic variants thereof, which elicit in a treated animal the formation of an immune response which is effective to treat or protect against Lyme disease as caused by infection with B. burgdorferi. Anti-OspA and anti-OspB antibodies that are effective to treat or protect against Lyme disease as caused by infection with B. burgdorferi. A screening method for the selection of those OspA and OspB polypeptides and anti-OspA and anti-OspB antibodies that are useful for the prevention and detection of Lyre disease. Diagnostic kits including OspA and OspB polypeptides or antibodies directed against such polypeptides.
Tick Antigens And Compositions And Methods Comprising Them
US Patent:
2001004, Nov 29, 2001
Filed:
Dec 1, 2000
Appl. No.:
09/728914
Inventors:
Fred Kantor - Orange CT, US
Erol Fikrig - Guilford CT, US
Subrata Das - New Haven CT, US
Erol Fikrig - Guilford CT, US
Subrata Das - New Haven CT, US
International Classification:
A61K039/00, C12N009/00, C07H021/04, C12P021/02
US Classification:
424/185100, 435/069300, 435/325000, 536/023200, 435/183000
Abstract:
Methods and compositions for conferring tick immunity and preventing or reducing the transmission of tick-borne pathogens. Tick polypeptides, fragments and derivatives; fusion and multimeric proteins comprising the polypeptides, fragments or derivatives; nucleic acid molecules encoding them; antibodies directed against the polypeptides, fusion proteins or multimeric proteins and compositions comprising the antibodies. Vaccines comprising the polypeptides, fragments or derivatives, alone or in addition to other protective polypeptides. Methods comprising the polypeptides, antibodies and vaccines.
Ospe, Ospf, And S1 Polypeptides In Borrelia Burgdorferi
US Patent:
5656451, Aug 12, 1997
Filed:
Sep 8, 1993
Appl. No.:
8/118469
Inventors:
Richard A. Flavell - Killingworth CT
Erol Fikrig - Guilford CT
Tuan T. Lam - San Jose CA
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Tuan T. Lam - San Jose CA
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Assignee:
Yale University - New Haven CT
International Classification:
C12P 2106, C12N 500, C12N 1500, C07H 1700
US Classification:
435 691
Abstract:
Methods and compositions for the prevention, treatment and diagnosis of Lyme disease. Novel B. burgdorferi polypeptides, serotypic variants thereof, fragments thereof and derivatives thereof. Fusion proteins and multimeric proteins comprising same. Multicomponent vaccines comprising novel B. burgdorferi polypeptides in addition to other immunogenic B. burgdorferi polypeptides. DNA sequences, recombinant DNA molecules and transformed host cells useful in the compositions and methods. Antibodies directed against the novel B. burgdorferi polypeptides, and diagnostic kits comprising the polypeptides or antibodies.
Ospe, Ospf, And S1 Polypeptides In Borrelia Burgdorferi
US Patent:
5807685, Sep 15, 1998
Filed:
Aug 11, 1997
Appl. No.:
8/909119
Inventors:
Richard A. Flavell - Killingworth CT
Erol Fikrig - Guilford CT
Tuan T. Lam - San Jose CA
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Tuan T. Lam - San Jose CA
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Assignee:
Yale University - New Haven CT
International Classification:
G01N 3353, C07K 14235
US Classification:
435 71
Abstract:
Methods and compositions for the prevention, treatment and diagnosis of Lyme disease. Novel B. burgdorferi polypeptides, serotypic variants thereof, fragments thereof and derivatives thereof. Fusion proteins and multimeric proteins comprising same. Multicomponent vaccines comprising novel B. burgdorferi polypeptides in addition to other immunogenic B. burgdorferi polypeptides. DNA sequences, recombinant DNA molecules and transformed host cells useful in the compositions and methods. Antibodies directed against the novel B. burgdorferi polypeptides, and diagnostic kits comprising the polypeptides or antibodies.
Compositions And Methods For The Prevention And Diagnosis Of Lyme Disease
US Patent:
5747294, May 5, 1998
Filed:
Oct 7, 1994
Appl. No.:
8/320161
Inventors:
Richard A. Flavell - Killingworth CT
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Fred S. Kantor - Orange CT
Stephen W. Barthold - Madison CT
Erol Fikrig - Guilford CT
Assignee:
Yale University - New Haven CT
International Classification:
C12P 2108, C07K 1612, A61K 3902, A61K 39395
US Classification:
435 7021
Abstract:
Methods and compositions for the prevention and diagnosis of Lyme disease. OspA and OspB polypeptides and serotypic variants thereof, which elicit in a treated animal the formation of an immune response which is effective to treat or protect against Lyme disease as caused by infection with B. burgdorferi. Anti-OspA and anti-OspB antibodies that are effective to treat or protect against Lyme disease as caused by infection with B. burgdorferi. A screening method for the selection of those OspA and OspB polypeptides and anti-OspA and anti-OspB antibodies that are useful for the prevention and detection of Lyme disease. Diagnostic kits including OspA and OspB polypeptides or antibodies directed against such polypeptides.